Trials / Terminated
TerminatedNCT03125408
Clinical Performance Evaluation of DxN HCV Assay
Clinical Utility of the DxN HCV Assay as an Aid in the Management of HCV-Infected Individuals Undergoing Antiviral Therapy
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 210 (actual)
- Sponsor
- Beckman Coulter, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The DxN Hepatitis C Virus (HCV) Assay is an in vitro diagnostic assay intended as an aid in the management of of HCV-infected individuals undergoing antiviral therapy. The purpose of the study is to establish the clinical performance of the DxN HCV Assay for plasma samples in the intended use population.
Detailed description
Same as brief
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | HCV Assay | Molecular diagnostic test to detect Hepatitus C |
Timeline
- Start date
- 2012-05-02
- Primary completion
- 2017-08-30
- Completion
- 2017-08-30
- First posted
- 2017-04-24
- Last updated
- 2018-07-12
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03125408. Inclusion in this directory is not an endorsement.